Deciphera PharmaceuticalsDCPH
13F holders, Q2 2024 (June 30)1holders −176
0new positions
175sold out
$15.18avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Deciphera Pharmaceuticals Inc. (DCPH) in their 13F filings, down 176 from Q1 2024. 0 opened new positions and 175 sold out. The largest holder was DekaBank Deutsche Girozentrale ($759K).
- Company
- Deciphera Pharmaceuticals Inc.
- CUSIP
- 24344T101
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 175 | $942.3M |
All 13F filers, Q1 2024 → Q2 2024: 59,907,649 shares sold, net −59,907,649 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| DekaBank Deutsche Girozentrale | 0.00% | No change | 50,000 | $759K |
"% of holder's portfolio" is DCPH's weight in each manager's 13F, not the share of Deciphera Pharmaceuticals Inc. the manager owns.